ObjectiveHealth, a Nashville, TN-based integrated specialty research network and technology company, received a strategic growth investment from Vitruvian Partners.
The amount of the deal was not disclosed.
The company intends to use the funds to expand its operations and continue its growth.
Led by CEO Colleen Hoke, ObjectiveHealth is an integrated research provider, partnering with physicians and healthcare organizations on one side, and pharmaceutical companies and CROs on the other side, to establish an advanced infrastructure for research programs as a natural extension of patient care. Utilizing proprietary AI-driven technology and trained on-site personnel, ObjectiveHealth delivers advances in the facilitation of clinical trial recruitment and conduct of clinical research, benefiting clients and practice partners while providing broader care options for patients.
As part of ObjectiveHealth’s continued expansion, in 2023 the company:
- Opened its 30th research center in Amarillo, Texas.
- Launched ObjectiveScreen, an AI-powered feasibility and recruitment platform to optimize clinical trial performance.
- Unveiled ObjectiveView, a technology portal that provides the sponsors of clinical trials with transparency into the process.
- Continued to expand its research portfolio into dermatology, urology and oncology, in addition to gastroenterology, at its partnered research sites across the country.